← Back to Discover
Prosight Management, LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $580,350,212
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- LAKEFRONT BIOTHERAPEUTICS NV · SPON ADR · 36315X101 · shares: $61,259,453
- JANUX THERAPEUTICS INC · COM · 47103J105 · shares: $58,436,828
- NEKTAR THERAPEUTICS · COM NEW · 640268306 · shares: $56,546,100
- BOSTON SCIENTIFIC CORP · COM · 101137107 · shares: $54,215,252
- SHATTUCK LABS INC · COM · 82024L103 · shares: $41,347,666
- INSMED INC · COM PAR $.01 · 457669307 · shares: $40,047,432
- ALNYLAM PHARMACEUTICALS INC · COM · 02043Q107 · shares: $29,525,022
- SYNDAX PHARMACEUTICALS INC · COM · 87164F105 · shares: $26,232,000
- KURA ONCOLOGY INC · COM · 50127T109 · shares: $22,180,945
- ALKERMES PLC · SHS · G01767105 · shares: $20,664,012
Reported holdings
36 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | SPON ADR | 36315X101 | — | 2,043,344 shares | $61,259,453 |
| JANUX THERAPEUTICS INC | COM | 47103J105 | — | 3,804,481 shares | $58,436,828 |
| NEKTAR THERAPEUTICS | COM NEW | 640268306 | — | 810,000 shares | $56,546,100 |
| BOSTON SCIENTIFIC CORP | COM | 101137107 | — | 1,270,273 shares | $54,215,252 |
| SHATTUCK LABS INC | COM | 82024L103 | — | 5,957,877 shares | $41,347,666 |
| INSMED INC | COM PAR $.01 | 457669307 | — | 375,609 shares | $40,047,432 |
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | — | 98,080 shares | $29,525,022 |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | — | 1,200,000 shares | $26,232,000 |
| KURA ONCOLOGY INC | COM | 50127T109 | — | 2,021,964 shares | $22,180,945 |
| ALKERMES PLC | SHS | G01767105 | — | 394,389 shares | $20,664,012 |
| IRHYTHM HOLDINGS INC | COM | 450056106 | — | 165,500 shares | $19,686,225 |
| VEEVA SYS INC | CL A COM | 922475108 | — | 106,200 shares | $18,847,314 |
| ZYMEWORKS INC | COM | 98985Y108 | — | 674,434 shares | $17,629,705 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 107,394 shares | $14,311,324 |
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | — | 374,666 shares | $14,020,002 |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | — | 449,795 shares | $12,135,469 |
| ADC THERAPEUTICS SA | SHS | H0036K147 | — | 7,824,749 shares | $8,372,481 |
| ICU MED INC | COM | 44930G107 | — | 51,000 shares | $7,476,600 |
| INTUITIVE SURGICAL INC | COM NEW | 46120E602 | — | 17,000 shares | $6,760,560 |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | — | 650,000 shares | $6,097,000 |
| PROCEPT BIOROBOTICS CORP | COM | 74276L105 | — | 268,269 shares | $6,057,514 |
| GENEDX HOLDINGS CORP | COM CL A | 81663L200 | — | 85,500 shares | $5,869,575 |
| OPTION CARE HEALTH INC | COM NEW | 68404L201 | — | 270,716 shares | $5,676,915 |
| ONKURE THERAPEUTICS INC | COM CL A | 68277Q105 | — | 978,992 shares | $4,464,204 |
| EMERGENT BIOSOLUTIONS INC | COM | 29089Q105 | — | 459,952 shares | $3,854,398 |
| PFIZER INC | COM | 717081103 | — | 135,366 shares | $3,259,613 |
| ORTHOPEDIATRICS CORP | COM | 68752L100 | — | 157,500 shares | $3,012,975 |
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | — | 700,000 shares | $2,394,000 |
| AN2 THERAPEUTICS INC | COM | 037326105 | — | 474,638 shares | $2,297,248 |
| PLIANT THERAPEUTICS INC | COM | 729139105 | — | 1,370,233 shares | $1,562,066 |
| TECTONIC THERAPEUTIC INC | COM | 878972108 | — | 39,731 shares | $1,365,753 |
| MEIRAGTX HLDGS PLC | COM | G59665102 | — | 90,000 shares | $1,215,900 |
| EVERFORTH INC | COM | 00191U102 | — | 67,500 shares | $1,206,225 |
| REIN THERAPEUTICS INC | COM NEW | 00887A204 | — | 1,100,000 shares | $1,144,000 |
| COYA THERAPEUTICS INC | COMMON STOCK | 22407B108 | — | 170,000 shares | $994,500 |
| IMMUNEERING CORP | CLASS A COM | 45254E107 | — | 36,861 shares | $183,936 |